San Diego, California–(Newsfile Corp. – March 31, 2022) – Felicity Pharma, the leading women-focused psychedelic biotech company, will be participating in the Benzinga Psychedelics Capital Conference which will take place on April 19 at the Fontainebleau Miami Beach.
Olivia Mannix will be speaking at 4:40 ET on April 19th. Interested parties can register to attend here.
Members of the Felicity Pharma management will also be holding one-on-one investor meetings throughout the day.
“We’re glad to welcome the burgeoning psychedelics industry into Benzinga’s growing ecosystem of events. We’ve seen cannabis businesses raise hundreds of millions of dollars at our Cannabis Capital Conferences and it’s our pleasure to open this possibility to businesses working to develop and establish psychedelics as the new paradigm-shift in mental health treatment,” said Chief Zinger Jason Raznick.
To register and access please follow this link.
About Felicity Pharma
Felicity Pharma is the leading women’s focused biotech company using psychedelics for the treatment of mood disorders in women. They are passionate about changing the paradigm when it comes to women and their medical needs.Felicity is disrupting the existing antidepressant market and working with novel psychedelic compounds to develop solutions for various female-specific disorders.
About The Benzinga Psychedelics Capital Conference
The premier gathering of psychedelic entrepreneurs and investors in North America is debuting in Miami.
The debut of the Benzinga Psychedelics Capital Conference will gather the biggest players in the psychedelics industry on April 19 in Miami. Attendees can expect a full day of company presentations, insider panels and networking.
The Benzinga Psychedelic Capital Conference is guaranteed to offer participants a chance to connect with the people driving the psychedelics industry forward. Join live in Miami or online anywhere to participate in this Psychedelics industry conference with top industry players.
For further information:
Cannabrand
(303) 223-7411
info@cannabrand.us
